Number of the records: 1
interferón beta-1a
SYS d000068556 LBL 00000nz--a2200181n--4500 005 20250606221736.3 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D12.644.276.374.440.890.275.500 065 $a D12.776.467.374.440.890.275.500 065 $a D23.529.374.440.890.275.500 066 $a 01 $c 03 150 $a interferón beta-1a $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a interferón beta 1a $2 slo 550 $7 sllk_us_auth*d000276 $Y Adjuvants, Immunologic $w P $a adjuvanciá imunologické 550 $7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká 550 $7 sllk_us_auth*d000998 $Y Antiviral Agents $w P $a antivirotiká 665 $a 2016 (1994) $2 eng 680 9-
$i An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS. $2 eng 750 -2
$a Interferon beta-1a $2 eng 980 $x M
Number of the records: 1